Long‐Term Results of Atrioventricular Node Ablation After His Bundle Pacing in Uncontrolled Atrial Tachyarrhythmias.

Introduction: In the evolving treatment of atrial fibrillation (AF), atrioventricular (AV) node ablation is being reconsidered as an early option for patients with inadequate AF control and limited cure potential. Although interest in physiological pacing is growing, concerns about the long‐term saf...

Descripción completa

Detalles Bibliográficos
Publicado en:Pacing & Clinical Electrophysiology Vol. 48; no. 7; pp. 799 - 807
Autores principales: Moraleda‐Salas, María Teresa, Erkoreka‐Gasituaga, Ane, Perea‐Alfaro, Carlos, Esteve‐Ruiz, Irene, Arce‐León, Álvaro, Carreño‐Lineros, José Miguel, Amigo‐Otero, Emilio, Moraleda‐Salas, María del Mar, Camacho‐Freire, Santiago, Navarro‐Roldan, Francisco, Moriña‐Vázquez, Pablo
Formato: diagnostic images research tables/charts tracings Journal Article
Publicado: Wiley-Blackwell Jul2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=186991085&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 186991085
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01478389
        4F8
      jtl: Pacing & Clinical Electrophysiology
      issn: 01478389
      maglogo: Y
    pubinfo:
      dt: Jul2025
      vid: 48
      iid: 7
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        186991085
        186010397
        186991085
        186991085
        10.1111/pace.70000
        186991085
      ppf: 799
      ppct: 8
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Long‐Term Results of Atrioventricular Node Ablation After His Bundle Pacing in Uncontrolled Atrial Tachyarrhythmias.
      aug:
        au:
          Moraleda‐Salas, María Teresa
          Erkoreka‐Gasituaga, Ane
          Perea‐Alfaro, Carlos
          Esteve‐Ruiz, Irene
          Arce‐León, Álvaro
          Carreño‐Lineros, José Miguel
          Amigo‐Otero, Emilio
          Moraleda‐Salas, María del Mar
          Camacho‐Freire, Santiago
          Navarro‐Roldan, Francisco
          Moriña‐Vázquez, Pablo
        affil: Arrhythmia Unit, Department of Cardiology, Hospital Juan Ramon Jimenez, Huelva, Spain
      sug:
        subj:
          Atrioventricular Node Physiopathology
          Catheter Ablation Methods
          Ablation Techniques
          Tachycardia Surgery
          Atrial Fibrillation Surgery
          Atrioventricular Node Surgery
          Bundle of HIS Physiopathology
          Cardiac Pacing, Artificial Methods
          Treatment Outcomes
          Ventricular Ejection Fraction
          Readmission
          Cardiac Resynchronization Therapy
          Human
          Male
          Female
          Aged
          Aged, 80 and Over
          Descriptive Research
          Nonexperimental Studies
          Heart Rate
          Prospective Studies
          Postoperative Complications
          Tachycardia Drug Therapy
          Antiarrhythmia Agents Therapeutic Use
          Aged: 65+ years
          Aged, 80 & over
          Male
          Female
      ab: Introduction: In the evolving treatment of atrial fibrillation (AF), atrioventricular (AV) node ablation is being reconsidered as an early option for patients with inadequate AF control and limited cure potential. Although interest in physiological pacing is growing, concerns about the long‐term safety of permanent His bundle pacing (p‐HBP) persist. Our current study aims to evaluate the long‐term outcomes of patients who underwent AV node ablation and p‐HBP, focusing on left ventricular ejection fraction (LVEF), NYHA class, readmissions, and pacing parameters. Methods: This descriptive observational study involved patients with uncontrolled permanent atrial arrhythmias who were eligible for heart rate (HR) control (between January 2019 and July 2020) and underwent p‐HBP and AV node ablation, followed during a near 4‐year period. Results: We conducted a long‐term follow‐up study with a median duration of 47 months on 32 patients who received p‐HBP followed by AV node ablation. The average age was 77 years, predominantly female (65.6%), with a high prevalence of hypertension (90.6%). The main indications for ablation were uncontrolled AF (59.4%) and atypical atrial flutter (37.5%). At baseline, the median LVEF was 60%. Notably, LVEF improved significantly from 45% to 50% in those with reduced baseline function (p < 0.05). NYHA class improvements were also observed over time. The His thresholds remained similar during long‐term follow‐up, being 1.25 V at 0.4 ms (1.25–2.4 V at 0.4 ms) before AV node ablation and 1.30 V at 0.4 ms (0.75–2.25 V at 0.4 ms), p = 0.89, at long‐term follow‐up. The impedances remained stable. No complications related to the pacemaker occurred. Number of medications per patient for HR control significantly decreased from 1.6 to 0.37 (p < 0.05), while hospital admissions for tachyarrhythmias dropped markedly. There was one death during the follow‐up due to cancer, but conclusions regarding mortality are limited by the small sample size. Conclusions: AV node ablation and p‐HBP significantly improve functional class and LVEF, with benefits maintained over time. Patients experience fewer emergency visits and reduced HR medication. Pacing parameters remained stable during long‐term follow‐up.
      pubtype: Academic Journal
      doctype:
        diagnostic images
        research
        tables/charts
        tracings
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N